The Business Times
business-time-50

US FDA declines to approve Spectrum Pharmaceuticals’ lung cancer drug

google-preferred-sourceAdd BT as a preferred source
Published Fri, Nov 25, 2022 · 07:40 PM
    • The FDA’s decision is in line with an advisory panel’s recommendation to not approve the drug.
    • The FDA’s decision is in line with an advisory panel’s recommendation to not approve the drug. PHOTO: REUTERS

    DeeperDive is a beta AI feature. Refer to full articles for the facts.

    SPECTRUM Pharmaceuticals said on Friday (Nov 25) the US Food and Drug Administration (FDA) declined to approve its experimental lung cancer drug, citing the need for an additional study.

    The company now plans to de-prioritise the development of the drug, called poziotinib, and said it was in the process of cutting 75 per cent of its research and development workforce.

    Spectrum had 164 employees as of Dec 31, 2021.

    The health regulator’s decision is in line with an advisory panel’s recommendation to not approve the drug. REUTERS

    Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.

    drugmakerCancerHealth

    Share with us your feedback on BT's products and services

    Feedback

    TRENDING NOW

    Property-based taxes may have limited room to run – and pushing them further risks hitting the wrong people, observers say.

    In taxing wealth, how far can Singapore push property owners?

    In this economy, the smartest bets might no longer be sitting an ocean away, but are waiting right here at home.

    ‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival

    Malaysia Madani, or Civil Malaysia, is Prime Minister Anwar Ibrahim's slogan encapsulating positive values (such as humanity and strong governance) that would shape policy direction. But the "corporate mafia" claims have now cast the spotlight on governance credibility.

    From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?

    The fourth Amity Circle retreat was hosted by Temasek Foundation from Apr 8 to 10 in Hanoi.

    Middle East-linked energy supply shocks put Asean Power Grid back in focus

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More